Recro Pharma, Inc. (REPH) NASDAQ

2.09

-0.00999999(-0.48%)

Updated at March 22, 2022 12:00AM

Currency In USD

Valuation

Market Cap199.03B
Enterprise Value199.06B
P/E Ratio-7.89
PEG Ratio-0.12
Price/Sales Ratio1.23
Price/Book Ratio1.79
Enterprise/Revenue2
Enterprise/EBITDA26.49

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterDecember 31, 2023

Profitability

Profit Margin-0.14
Operating Margin-0.02

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.22

Income Statement

Revenue94.64M
Revenue/Share0.99
Gross Profit18.14M
EBITDA-3.57M
Net Income-13.27M
Diluted EPS-0

Balance Sheet

Total Cash8.1M
Total Cash/Share0.09
Total Debt42.01M
Total Debt/Equity1.39
Current Ratio1.07
Book Value Per Share0.62

Price History

52-Week Change19.43
52-Week High3.29
52-Week Low1.38
Moving Average 50 Days1.73
Moving Average 200 Days1.87

Statistics

Average Volume128,488
Shares Outstanding84.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor223:200
Last Split DateNovember 22, 2019
AboutPrivacy PolicyContact usTerms & Conditions

Copyright © 2025 Stoculator.com. All rights reserved